Every 10-Q that SUNHYDROGEN INC. (HYSR) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow HYSR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full HYSR filings page.
SunHydrogen, Inc. reported another development-stage quarter with no revenue for the three months ended March 31, 2026 and a net loss of $1,534,383, slightly narrower than a year earlier. For the nine-month period, the company generated consulting revenue of $1,250 and recorded a net loss of $4,592,609 versus $7,255,839 in the prior-year period, mainly because last year included a large unrealized loss on its TECO investment.
Cash and cash equivalents declined to $13,073,063 from $34,628,625 at June 30, 2025, while short-term investments rose to $19,805,295. Working capital was $33,053,907, supporting ongoing research and development spending of $3,110,003 for the nine months, up from $2,369,119. The company continued simplifying its capital structure by repurchasing and converting Series C Preferred Stock and raising equity under a common stock purchase agreement. Management again disclosed a material weakness in internal control over financial reporting related to segregation of duties, though it believes the financial statements are fairly presented.
SunHydrogen, Inc. reported another development-stage quarter for the period ended December 31, 2025, with no revenue for the quarter and only $1,250 in consulting revenue over six months. The company focuses on nanoparticle-based and thin-film solar technologies to produce green hydrogen from sunlight and water.
Quarterly operating expenses rose to $1.67 million, driven mainly by higher research and development and general and administrative costs, leading to a net loss of $1.50 million, improved from a $3.47 million loss a year earlier. For the six months, the net loss was $3.06 million, compared with $5.52 million in the prior-year period, largely because last year included a large unrealized loss on the TECO investment that is now carried at zero value.
SunHydrogen ended the period with $14.41 million in cash and cash equivalents and $19.83 million in short-term investments, for total assets of $34.49 million and working capital of $33.57 million. The company used cash for operations and to repurchase $1.0 million of Series C preferred stock, while moving a significant portion of cash into short-term investments. Management states the business remains dependent on external financing and future revenue, and it continues to report a material weakness in internal control related to segregation of duties.
SunHydrogen, Inc. (HYSR) filed its quarterly report, highlighting continued R&D investment and a narrower loss. For the three months ended September 30, 2025, the company reported a net loss of $1,559,778, improved from $2,046,838 a year ago. Operating expenses rose to $1,924,395 as research and development increased to $1,198,719, while investment income contributed $377,170. Revenue was $1,250 from related-party consulting.
Liquidity remained strong with cash and cash equivalents of $33,465,159 and short-term investments of $1,978,096. Working capital surplus was $34,778,471 as of September 30, 2025. Cash used in operations was $1,186,098; investing provided $1,022,632 from Treasury activity; financing used $1,000,000 after repurchasing and canceling 1,486 shares of Series C preferred stock, leaving 5,165 outstanding (redeemable value $516,500).
The company noted a material weakness in internal controls related to segregation of duties. Shares outstanding were 5,438,414,015 as of November 10, 2025. SunHydrogen continues developing its nanoparticle-based and thin-film solar cell hydrogen production methodologies.